Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00795015 · ClinicalTrials.gov registry record · Phase 4
Comparison of the Leuven Protocol With the Glucommander for Postoperative Control of Blood Glucose With IV Insulin
A Phase 4 study, sponsored by Rush University Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 93
- Enrollment target
NCT00795015 is a Phase 4 study that has completed, run by Rush University Medical Center. The registered enrollment target is 93 participants.
The verdict
NCT00795015, a Phase 4 study, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 93 participants
- Enrollment target
Study Summary
The investigators are testing whether a written protocol or a computerized program can more effectively control blood glucose after surgery.
Interventions
- DRUG insulin regular IV infusion
- DRUG IV insulin infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2006-04 |
| Est. Completion | 2006-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00795015
The ClinicalTrials.gov registry entry for NCT00795015 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which insulin regular IV infusion is the first listed.
NCT00795015 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00795015 about?
NCT00795015 is a clinical study titled "Comparison of the Leuven Protocol With the Glucommander for Postoperative Control of Blood Glucose With IV Insulin". The investigators are testing whether a written protocol or a computerized program can more effectively control blood glucose after surgery.
What is the current status of trial NCT00795015?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 93 participants. The study started on 2006-04. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00795015?
The interventions under investigation include: insulin regular IV infusion (DRUG), IV insulin infusion (DRUG).
Who is sponsoring clinical trial NCT00795015?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.